Patients who would benefit from early-line treatment bispecific antibodies

After step-up dosing, treatment with bispecific antibodies does not require the use of steroids, Adams noted, so patients are spared steroid side effects. Bispecific antibody treatment advances could also mean avoiding proteasome inhibitors, which cause neuropathy, she said.